Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LIFW
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -50.76 0.23 0.47
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -138.25 -76.01 -31.90
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -5.85 17.49 18.58
Cash 0.50 0.80 0.79
Capex 30.53 < 0.005 -0.01
Free Cash Flow 74.29 -0.15 -0.59
Revenue 704.87 0.40 0.05
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 88.25 -19.46 -165.57
Operating Margin 88.88 -21.70 -195.08
ROA 16.22 < 0.005 < 0.005
ROE 16.52 -0.07 -0.09
ROIC 7.19 -0.01 -0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LIFW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LIFW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LIFW is permitted for members.